Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma
Soft tissue sarcomas (STS) are a rare group of malignancies with multiple different subtypes. Close to half of intermediate or high grade STS develop metastatic disease. Treatment of recurrent/metastatic sarcomas is quite challenging with only a few drugs showing measurable benefits. Trabectedin (ec...
Main Authors: | Csaba Gajdos, Anthony Elias |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S4907 |
Similar Items
-
Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
by: EL Simpson, et al.
Published: (2010-05-01) -
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
by: De Sanctis R, et al.
Published: (2015-10-01) -
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
by: De Sanctis R, et al.
Published: (2016-01-01) -
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01) -
Trabectedin for advanced soft tissue sarcomas: optimizing use
by: Reid A, et al.
Published: (2014-12-01)